Ionis Pharmaceuticals IONS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's operating lease ROU assets?
- Ionis Pharmaceuticals (IONS) reported operating lease ROU assets of $235.06M in Q1 2026.
- How has Ionis Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Ionis Pharmaceuticals's operating lease ROU assets increased by 47.6% year-over-year, from $159.27M to $235.06M.
- What is the long-term trend for Ionis Pharmaceuticals's operating lease ROU assets?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's operating lease ROU assets has grown at a 90.9% compound annual growth rate (CAGR), from $17.97M to $238.55M.
- What does operating lease ROU assets mean?
- The asset value representing the right to use leased property or equipment.
- How do you interpret operating lease ROU assets?
- An increase reflects expansion of leased facilities or equipment, while a decrease may indicate lease expirations or asset impairment.
- How does operating lease ROU assets compare across companies?
- Standardized metric for all companies reporting under ASC 842 or IFRS 16.